Read more at MarketWatch.
Biogen’s stock bounces after FDA boost on kidney-transplant rejection treatment
Date: |
-
Business - MarketWatch
Viking Therapeutics’ stock boosted by positive data from trial of treatment for rare metabolic disorder X-ALD
Viking, which is also developing a weight-loss pill, has a buy rating from all 13 analysts offering coverage.3 hours ago -
Business - The New York Times
China Stocks Surge After Government Measures to Boost Economy
The government has fired up investors by encouraging banks to lend more to buyers of stocks and real estate, but officials refrained on Tuesday from promising more stimulus.20 hours ago - China -
Business - MarketWatch
Sage Therapeutics’ stock slides after biotech says it will cease development of Alzheimer’s treatment
Sage Therapeutics Inc.’s stock tumbled 12.8% early Tuesday, after the company said a mid-stage trial of a treatment for mild cognitive impairment and mild dementia in Alzheimer’s disease failed to ...Yesterday -
Business - MarketWatch
WeightWatchers’ stock soars after adding compounded GLP-1 treatment to its offering
“With the addition of compounded semaglutide [GLP-1], we are expanding our offering to include a clinical weight management solution that is both accessible and affordable,” said Interim Chief ...Yesterday -
Business - MarketWatch
Lucid’s stock climbs, boosted by jump in vehicle deliveries
Lucid’s third-quarter vehicle deliveries are up 90% year-over-year.2 days ago -
Business - MarketWatch
Scholar Rock’s stock soars more than 315% on positive trial of treatment for spinal muscular atrophy
The Phase 3 trial of apitegromab showed statistically significant improvement in motor function.2 days ago -
Top stories - BBC News
China stock rally fizzles as stimulus news disappoints
Shares fell back after a news conference by economic planners gave little in the way of details.Yesterday - China -
Business - MarketWatch
‘DJT’ stock soars after Elon Musk joins Trump at Butler rally
The stock is on pace for its biggest gain since July 15, the first trading session after an assassination attempt against Donald Trump in Pennsylvania.Yesterday - Elon Musk
More from MarketWatch
-
Business - MarketWatch
Why a CPI surprise could trip up the Fed’s rate-cutting plans
Employment and economic data already are surprising to the upside since the Federal Reserve cut rates in September2 hours ago -
Business - MarketWatch
Rio Tinto strikes $6.7 billion deal to buy Arcadium Lithium
Rio Tinto on Wednesday struck a deal to acquire Arcadium Lithium for $6.7 billion, as the global miner extends its operations in another commodity needed for the energy transition.2 hours ago -
Business - MarketWatch
Inflation still slowing, CPI to show, but some warning signs might flash
The rate of U.S. inflation is likely to slow again in September, but fresh doubts have emerged about whether the Federal Reserve can hit its 2% target earlier than expected.2 hours ago -
Business - MarketWatch
U.S., and intriguingly, Australia, have the most expensive stocks by one measure
Why one trader says most U.S. stocks are expensive, and many foreign ones are cheap.2 hours ago -
Business - MarketWatch
How this 34-year-old went from working in retail to owning her own restaurant
Jackie Podhurst worked for Target and Macy’s before opening a restaurant in New Jersey.3 hours ago